Delivery Order SPE2DB20D3103-SPE2DB25FN8G7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). This is a firm fixed-price, non-set-aside delivery order issued on November 4, 2025, with an ultimate completion date of November 26, 2025. YONSA is a prescription medication used in oncology treatment, and the order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,271.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of YONSA 125 mg, a prescription medication used in oncology treatment. This non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of YONSA 125 mg tablets (120-count units) with a ceiling value of $2,271.36 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count units) valued at $2,271.36 under a firm fixed price contract type. This non-competitive delivery order, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,542.74 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count supply). The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that...
- The Defense Logistics Agency awarded a delivery order valued at $18,170.88 to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120-count units) on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This is a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for YONSA 125 mg tablets (120 count) on August 12, 2025, with a ceiling value of $2,271.36. This firm fixed-price delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of YONSA 125 mg tablets (120 count). This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, is to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation and represents a child contract under AmerisourceBergen's larger federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Yonsa 125 mg tablets (120-count units) valued at $2,271.36 with a firm fixed price structure. The order is scheduled for completion by May 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's existing...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN8G7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,814.08 to AmerisourceBergen Drug Corp on May 14, 2025, for the supply of YONSA 125 mg tablets (120-count units). This firm fixed-price delivery order, with an ultimate completion date of June 5, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. YONSA is a prescription medication used in cancer treatment, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies to federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare systems globally, including the Defense Health Agency, U.S. Coast Guard, and other federal medical programs. AmerisourceBergen's position as a major pharmaceutical distributor and established federal contractor demonstrates its capability to fulfill diverse and time-sensitive medical supply requirements across multiple therapeutic domains for the Department of Defense and its beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 5/14/25 |